28 May 2019 12:00 pm Place Main Lecture Hall - Salón de Actos CIB Contact Daniel Lietha Discovery and preclinical investigation of the first Type II inhibitor of the SRC kinase. Department Structural and Chemical Biology Speaker Asier Unciti-Broceta FRSC. Personal Chair of Medicinal Chemistry and Head of the Innovative Therapeutics Lab. Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, The University of Edinburgh. Downloads Unciti-Broceta.pdf